Latvia vs North Macedonia: Prevalence of anemia among women of reproductive age
Latvia
21.4%
in 2023
North Macedonia
21.5%
in 2023
Latvia rank
132nd
North Macedonia rank
130th
Prevalence of anemia among women of reproductive age over time
- Latvia
- North Macedonia
How they compare
North Macedonia currently reports 21.5% against 21.4% in Latvia, a difference of 0.1%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Latvia ahead.
Latvia ranks 132nd and North Macedonia ranks 130th of 192 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.8% | 15.4% | 4.4% | Latvia |
| 2010s | 19.6% | 17.5% | 2.0% | Latvia |
| 2020s | 20.9% | 20.4% | 0.4% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, Latvia or North Macedonia?
- North Macedonia, at 21.5% against 21.4% in Latvia as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between Latvia and North Macedonia?
- 0.1%, with North Macedonia ahead.
- How many years of comparable data are there for Latvia and North Macedonia?
- 24 years are reported by both, from 2000 to 2023.
- How do Latvia and North Macedonia rank globally for prevalence of anemia among women of reproductive age?
- Latvia ranks 132nd and North Macedonia ranks 130th of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.